Accolade, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACCD research report →
Companywww.accolade.com
Accolade, Inc. , together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.
- CEO
- Rajeev Singh
- IPO
- 2020
- Employees
- 2,400
- HQ
- Plymouth Meeting, PA, US
Price Chart
Valuation
- Market Cap
- $575.59M
- P/E
- -5.27
- P/S
- 1.39
- P/B
- 1.18
- EV/EBITDA
- -9.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 46.36%
- Op Margin
- -27.63%
- Net Margin
- -24.09%
- ROE
- -21.71%
- ROIC
- -16.65%
Growth & Income
- Revenue
- $414.29M · 14.09%
- Net Income
- $-99,805,000 · 78.29%
- EPS
- $-1.33 · 79.38%
- Op Income
- $-114,453,000
- FCF YoY
- 40.23%
Performance & Tape
- 52W High
- $9.67
- 52W Low
- $3.08
- 50D MA
- $6.95
- 200D MA
- $4.78
- Beta
- 2.10
- Avg Volume
- 1.57M
Get TickerSpark's AI analysis on ACCD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 25 | SINGH RAJEEV | other | 175,000 |
| Apr 8, 25 | SINGH RAJEEV | other | 136,293 |
| Apr 8, 25 | SINGH RAJEEV | sell | 175,000 |
| Apr 8, 25 | SINGH RAJEEV | sell | 904,809 |
| Apr 8, 25 | SINGH RAJEEV | sell | 18,125 |
| Apr 8, 25 | SINGH RAJEEV | sell | 12,500 |
| Apr 8, 25 | SINGH RAJEEV | sell | 17,846 |
| Apr 8, 25 | SINGH RAJEEV | sell | 120,600 |
| Apr 8, 25 | SINGH RAJEEV | sell | 504,469 |
| Apr 8, 25 | SINGH RAJEEV | sell | 651,619 |
Our ACCD Coverage
We haven't published any research on ACCD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACCD Report →